First Biotech (Australia)

Company snapshot

First Biotech (Australia) maintains 126 tracked programs across Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosis, Obesity, Overweight, Pulmonary Arterial Hypertension, Moderate-to-Severe Atopic Dermatitis, METASTATIC CASTRATION RESISTANT PROSTATE CANCER, Cancer cachexia, recurrent/refractory Ewing sarcoma, recurrent or refractory ne

• 76 approved product(s) across US/EU regulatory metadata.
• 126 active pipeline program(s) linked via ClinicalTrials.gov.
• 126 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for First Biotech (Australia). Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for First Biotech (Australia).

1. Jun 8, 2026 Clinical update

   C4391010 — Phase 1

2. Jun 8, 2026 Clinical update

   C4151006 — Phase 1

3. Jun 8, 2026 Clinical update

   B7451015 — Phase 3

4. Jun 8, 2026 Clinical update

   A Study to Learn If the Study Medicine Called... — Phase 1

5. Jun 8, 2026 Clinical update

   C6461013 — Phase 2

View all clinical trial activity →

• What is First Biotech (Australia)?

  Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosis. NovaPharmaNews links 126 clinical program(s), 70 drug pro

• Is First Biotech (Australia) publicly traded?

  First Biotech (Australia) appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does First Biotech (Australia) develop or market?

  We link 208 drug profile(s) where First Biotech (Australia) is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company#company-drugs.

• What are the latest developments for First Biotech (Australia)?

  In the last 12 months our linked public records show 126 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does First Biotech (Australia) focus on?

  First Biotech (Australia) focuses on Alopecia areata, Multiple myeloma, Heart failure based on our analysis of their pipeline programs and drug development activities.